139 related articles for article (PubMed ID: 33011400)
1. Differences in biomarkers of inflammation and immune responses in chronic smokers and moist snuff users.
Tran QT; Arimilli S; Scott E; Chen P; Prasad GL
Cytokine; 2021 Jan; 137():155299. PubMed ID: 33011400
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles associated with cigarette smoking and moist snuff consumption.
Arimilli S; Madahian B; Chen P; Marano K; Prasad GL
BMC Genomics; 2017 Feb; 18(1):156. PubMed ID: 28193179
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers.
Prasad GL; Jones BA; Chen P; Gregg EO
Clin Chem Lab Med; 2016 Apr; 54(4):633-42. PubMed ID: 26495926
[TBL] [Abstract][Full Text] [Related]
4. Pathway Analysis of Global Metabolomic Profiles Identified Enrichment of Caffeine, Energy, and Arginine Metabolism in Smokers but Not Moist Snuff Consumers.
Liu G; Lee DP; Schmidt E; Prasad GL
Bioinform Biol Insights; 2019; 13():1177932219882961. PubMed ID: 31666793
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory profile analysis reveals differences in cytokine expression between smokers, moist snuff users, and dual users compared to non-tobacco consumers.
Sgambato JA; Jones BA; Caraway JW; Prasad GL
Cytokine; 2018 Jul; 107():43-51. PubMed ID: 29217402
[TBL] [Abstract][Full Text] [Related]
6. Global methylation profiles in buccal cells of long-term smokers and moist snuff consumers.
Jessen WJ; Borgerding MF; Prasad GL
Biomarkers; 2018 Nov; 23(7):625-639. PubMed ID: 29771158
[TBL] [Abstract][Full Text] [Related]
7. Study of cardiovascular disease biomarkers among tobacco consumers, part 1: biomarkers of exposure.
Campbell LR; Brown BG; Jones BA; Marano KM; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):149-56. PubMed ID: 25787703
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Potential Harm among Adult Cigarette and Smokeless Tobacco Users in the PATH Study Wave 1 (2013-2014): A Cross-sectional Analysis.
Chang JT; Vivar JC; Tam J; Hammad HT; Christensen CH; van Bemmel DM; Das B; Danilenko U; Chang CM
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1320-1327. PubMed ID: 33947655
[TBL] [Abstract][Full Text] [Related]
9. Smoking, use of moist snuff and risk of celiac disease: a prospective study.
Ludvigsson JF; Nordenvall C; Järvholm B
BMC Gastroenterol; 2014 Jul; 14():120. PubMed ID: 24994113
[TBL] [Abstract][Full Text] [Related]
10. The Case to Include Brand of Moist Snuff in Health Surveys.
Timberlake DS
Nicotine Tob Res; 2016 Aug; 18(8):1786-90. PubMed ID: 27020059
[TBL] [Abstract][Full Text] [Related]
11. Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey.
Marano KM; Kathman SJ; Jones BA; Nordskog BK; Brown BG; Borgerding MF
Inhal Toxicol; 2015 Feb; 27(3):167-73. PubMed ID: 25787702
[TBL] [Abstract][Full Text] [Related]
12. Comparison of blood aldehyde dehydrogenase activities in moist snuff users, cigarette smokers and nontobacco users.
Helander A; Curvall M
Alcohol Clin Exp Res; 1991 Feb; 15(1):1-6. PubMed ID: 2024719
[TBL] [Abstract][Full Text] [Related]
13. Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: results from a case-control study.
Jiang X; Alfredsson L; Klareskog L; Bengtsson C
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1582-6. PubMed ID: 24719251
[TBL] [Abstract][Full Text] [Related]
14. Smoking, use of moist snuff, and risk of chronic inflammatory diseases.
Carlens C; Hergens MP; Grunewald J; Ekbom A; Eklund A; Höglund CO; Askling J
Am J Respir Crit Care Med; 2010 Jun; 181(11):1217-22. PubMed ID: 20203245
[TBL] [Abstract][Full Text] [Related]
15. Examining market trends in the United States smokeless tobacco use: 2005-2011.
Delnevo CD; Wackowski OA; Giovenco DP; Manderski MT; Hrywna M; Ling PM
Tob Control; 2014 Mar; 23(2):107-12. PubMed ID: 23117999
[TBL] [Abstract][Full Text] [Related]
16. Relationships of Long-Term Smoking and Moist Snuff Consumption With a DNA Methylation Age Relevant Smoking Index: An Analysis in Buccal Cells.
Nwanaji-Enwerem JC; Cardenas A; Chai PR; Weisskopf MG; Baccarelli AA; Boyer EW
Nicotine Tob Res; 2019 Aug; 21(9):1267-1273. PubMed ID: 30053132
[TBL] [Abstract][Full Text] [Related]
17. Tobacco impact on quality of life, a cross-sectional study of smokers, snuff-users and non-users of tobacco.
Wachsmann S; Nordeman L; Billhult A; Rembeck G
BMC Public Health; 2023 May; 23(1):886. PubMed ID: 37189128
[TBL] [Abstract][Full Text] [Related]
18. Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys.
Tomar SL; Alpert HR; Connolly GN
Tob Control; 2010 Apr; 19(2):104-9. PubMed ID: 20008157
[TBL] [Abstract][Full Text] [Related]
19. Tobacco use and nicotine dependence among people living with HIV who drink heavily in South Africa: a cross-sectional baseline study.
Egbe CO; Londani M; Parry CDH; Myers B; Shuper PA; Nkosi S; Morojele NK
BMC Public Health; 2019 Dec; 19(1):1684. PubMed ID: 31842834
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
Tomar SL
Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
